Company Quick10K Filing
OranjTek
20-F 2020-12-31 Filed 2021-03-18
20-F 2019-12-31 Filed 2020-04-21
20-F 2018-12-31 Filed 2019-04-16
20-F 2018-04-04 Filed 2018-04-04
20-F 2017-04-07 Filed 2017-04-07
20-F 2016-04-04 Filed 2016-04-04
20-F 2015-04-14 Filed 2015-04-14
20-F 2013-12-31 Filed 2014-04-30
20-F 2012-12-31 Filed 2013-04-12
20-F 2011-12-31 Filed 2012-04-13
20-F 2010-12-31 Filed 2011-04-21
20-F 2009-12-31 Filed 2010-05-05

OranjTek Financials

ORAN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash5,5555,93410,77910,9847,9877,8395,3636,9277,0886,423
Accounts Receivable7,9587,4996,5736,1185,8865,3505,8515,4116,3146,036
Inventory9019498467748608229168931,0091,100
PP&E47,23433,17331,67031,23431,26227,04430,14828,24432,53131,570
Assets178,758126,330128,751118,774115,875102,549109,716103,188115,551110,115
Accounts Payable11,59511,71211,43210,60510,6506,6997,4726,7737,9637,679
Long-Term Debt53,62948,43052,76051,76250,48339,87340,87736,54139,43438,782
Liabilities135,57684,05489,09883,94780,32465,77569,79666,29774,66672,211
Stockholders' Equity43,18242,27639,65334,82735,55136,77339,92036,89140,88537,904
Income Statement ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue65,47460,97460,67157,44055,32445,75648,28344,37249,84847,174
Cost of Revenue27,37225,96226,31525,21224,25320,01121,23619,82322,42521,162
Gross Profit38,10235,01234,35632,22831,07225,74527,04724,54927,42326,013
R&D0000000000
SG&A13,15512,34711,81213,67912,17610,51710,8389,66410,4589,426
Tax3,2731,0122,7971,6251,8971,8257791,0371,2831,492
Net Income5,8216,5395,2191,0822,5291,0733,1823,1992,3252,228
Cash Flow ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating27,93616,86817,25813,2219,80010,21011,4329,53812,41210,837
Cash Investing-13,655-7,974-8,453-6,217-8,159-7,368-11,287-5,318-9,688-9,749
Cash Financing-16,041-8,197-3,832-6,695-4,775-179-4,709-2,052-3,340-1,289